切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - GPR40 - Pepsins - HMG-CoA Reductases - Topoisomerases

24件产品中的 1-10

页面
每页
清除全部
  1. (S)-10-Hydroxycamptothecin
    B4745 (S)-10-Hydroxycamptothecin
    中文名: 羟喜树碱
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.8 mg/mL
      insoluble in H2O
  2. Ellipticine
    B7382 Ellipticine
    中文名: 玫瑰树碱,椭圆玫瑰树碱
    Target: Topoisomerases
    Summary: DNA拓扑异构酶II抑制剂
      ≥24.6 mg/mL
      insoluble in H2O
  3. Pirarubicin
    B2295 Pirarubicin
     1 Citation
    中文名: 吡柔比星
    Target: Topoisomerases
    Summary: 拓扑异构酶II抑制剂,蒽环类抗生素
      ≥7.65 mg/mL
      insoluble in H2O
  4. Norfloxacin
    B1801 Norfloxacin
    中文名: 诺氟沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      insoluble in DMSO
      insoluble in H2O
  5. Mevastatin
    B1788 Mevastatin
    中文名: 美伐他汀
    Target: HMG-CoA Reductases
    Summary: HMG-CoA还原酶抑制剂
      ≥15.95 mg/mL
      insoluble in H2O
  6. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    中文名: 盐酸依立替康三水合物
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.1 mg/mL
      ≥2.5 mg/mL
  7. Beta-Lapachone
    B2290 Beta-Lapachone
    中文名: β-拉帕醌
    Target: Topoisomerases
    Summary: 选择性DNA拓扑异构酶I抑制剂
      ≥10.85 mg/mL
      insoluble in H2O
  8. Clinafloxacin CI96 AM1091
    A8400 Clinafloxacin CI96 AM1091
    中文名: 克林沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      ≥3.66 mg/mL
      insoluble in H2O
  9. Simvastatin (Zocor)
    A8522 Simvastatin (Zocor)
    中文名: 辛伐他汀
    Target: HMG-CoA Reductases
    Summary: HMGCR(HMG-CoA还原酶)抑制剂
      ≥20.95 mg/mL
      insoluble in H2O
  10. Pitavastatin Calcium
    A8504 Pitavastatin Calcium
     1 Citation
    中文名: 匹伐他汀钙
    Target: HMG-CoA Reductases
    Summary: 酶HMGCR抑制剂
      ≥34.85 mg/mL
      insoluble in H2O

24件产品中的 1-10

页面
每页